306 related articles for article (PubMed ID: 28635951)
1. New insights into the imprinted MEG8-DMR in 14q32 and clinical and molecular description of novel patients with Temple syndrome.
Beygo J; Küchler A; Gillessen-Kaesbach G; Albrecht B; Eckle J; Eggermann T; Gellhaus A; Kanber D; Kordaß U; Lüdecke HJ; Purmann S; Rossier E; van de Nes J; van der Werf IM; Wenzel M; Wieczorek D; Horsthemke B; Buiting K
Eur J Hum Genet; 2017 Aug; 25(8):935-945. PubMed ID: 28635951
[TBL] [Abstract][Full Text] [Related]
2. Paternal uniparental disomy chromosome 14-like syndrome due a maternal de novo 160 kb deletion at the 14q32.2 region not encompassing the IG- and the MEG3-DMRs: Patient report and genotype-phenotype correlation.
Corsello G; Salzano E; Vecchio D; Antona V; Grasso M; Malacarne M; Carella M; Palumbo P; Piro E; Giuffrè M
Am J Med Genet A; 2015 Dec; 167A(12):3130-8. PubMed ID: 26333487
[TBL] [Abstract][Full Text] [Related]
3. Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR.
Kagami M; Yanagisawa A; Ota M; Matsuoka K; Nakamura A; Matsubara K; Nakabayashi K; Takada S; Fukami M; Ogata T
Clin Epigenetics; 2019 Mar; 11(1):42. PubMed ID: 30846001
[TBL] [Abstract][Full Text] [Related]
4. The differentially methylated region of MEG8 is hypermethylated in patients with Temple syndrome.
Bens S; Kolarova J; Gillessen-Kaesbach G; Buiting K; Beygo J; Caliebe A; Ammerpohl O; Siebert R
Epigenomics; 2015 Oct; 7(7):1089-97. PubMed ID: 26541061
[TBL] [Abstract][Full Text] [Related]
5. Kagami-Ogata syndrome: a clinically recognizable upd(14)pat and related disorder affecting the chromosome 14q32.2 imprinted region.
Ogata T; Kagami M
J Hum Genet; 2016 Feb; 61(2):87-94. PubMed ID: 26377239
[TBL] [Abstract][Full Text] [Related]
6. Two infants with mild, atypical clinical features of Kagami-Ogata syndrome caused by epimutation.
Higashiyama H; Ohsone Y; Takatani R; Futatani T; Kosaki R; Kagami M
Eur J Med Genet; 2022 Oct; 65(10):104580. PubMed ID: 35953028
[TBL] [Abstract][Full Text] [Related]
7. Maternally inherited deletion encompassing the RTL1as and MEG8 genes of the human 14q32 imprinted region in a patient with a mild Kagami-Ogata syndrome phenotype.
Sirera Sirera P; García-Payá E; Olivas García J; Jadraque Rodríguez R; Hernández Romero SD
Am J Med Genet A; 2023 Aug; 191(8):2225-2231. PubMed ID: 37222159
[TBL] [Abstract][Full Text] [Related]
8. Novel deletions affecting the MEG3-DMR provide further evidence for a hierarchical regulation of imprinting in 14q32.
Beygo J; Elbracht M; de Groot K; Begemann M; Kanber D; Platzer K; Gillessen-Kaesbach G; Vierzig A; Green A; Heller R; Buiting K; Eggermann T
Eur J Hum Genet; 2015 Feb; 23(2):180-8. PubMed ID: 24801763
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of temple syndrome families with 14q32 epimutations.
Brück J; Begemann M; Dey D; Elbracht M; Eggermann T
Eur J Med Genet; 2020 Dec; 63(12):104077. PubMed ID: 33010492
[TBL] [Abstract][Full Text] [Related]
10. Epimutations of the IG-DMR and the MEG3-DMR at the 14q32.2 imprinted region in two patients with Silver-Russell Syndrome-compatible phenotype.
Kagami M; Mizuno S; Matsubara K; Nakabayashi K; Sano S; Fuke T; Fukami M; Ogata T
Eur J Hum Genet; 2015 Aug; 23(8):1062-7. PubMed ID: 25351781
[TBL] [Abstract][Full Text] [Related]
11. Novel microdeletions on chromosome 14q32.2 suggest a potential role for non-coding RNAs in Kagami-Ogata syndrome.
van der Werf IM; Buiting K; Czeschik C; Reyniers E; Vandeweyer G; Vanhaesebrouck P; Lüdecke HJ; Wieczorek D; Horsthemke B; Mortier G; Leroy JG; Kooy RF
Eur J Hum Genet; 2016 Dec; 24(12):1724-1729. PubMed ID: 27406249
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the non-imprinted maternal MEG3 and paternal MEST alleles is highly variable among normal individuals.
Haertle L; Maierhofer A; Böck J; Lehnen H; Böttcher Y; Blüher M; Schorsch M; Potabattula R; El Hajj N; Appenzeller S; Haaf T
PLoS One; 2017; 12(8):e0184030. PubMed ID: 28854270
[TBL] [Abstract][Full Text] [Related]
13. The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers.
Kagami M; O'Sullivan MJ; Green AJ; Watabe Y; Arisaka O; Masawa N; Matsuoka K; Fukami M; Matsubara K; Kato F; Ferguson-Smith AC; Ogata T
PLoS Genet; 2010 Jun; 6(6):e1000992. PubMed ID: 20585555
[TBL] [Abstract][Full Text] [Related]
14. Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes.
Kagami M; Sekita Y; Nishimura G; Irie M; Kato F; Okada M; Yamamori S; Kishimoto H; Nakayama M; Tanaka Y; Matsuoka K; Takahashi T; Noguchi M; Tanaka Y; Masumoto K; Utsunomiya T; Kouzan H; Komatsu Y; Ohashi H; Kurosawa K; Kosaki K; Ferguson-Smith AC; Ishino F; Ogata T
Nat Genet; 2008 Feb; 40(2):237-42. PubMed ID: 18176563
[TBL] [Abstract][Full Text] [Related]
15. Segmental paternal uniparental disomy (patUPD) of 14q32 with abnormal methylation elicits the characteristic features of complete patUPD14.
Irving MD; Buiting K; Kanber D; Donaghue C; Schulz R; Offiah A; Mohammed SN; Oakey RJ
Am J Med Genet A; 2010 Aug; 152A(8):1942-50. PubMed ID: 20602488
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 14q32.2 Imprinted Region Disruption as an Alternative Molecular Diagnosis of Silver-Russell Syndrome.
Geoffron S; Abi Habib W; Chantot-Bastaraud S; Dubern B; Steunou V; Azzi S; Afenjar A; Busa T; Pinheiro Canton A; Chalouhi C; Dufourg MN; Esteva B; Fradin M; Geneviève D; Heide S; Isidor B; Linglart A; Morice Picard F; Naud-Saudreau C; Oliver Petit I; Philip N; Pienkowski C; Rio M; Rossignol S; Tauber M; Thevenon J; Vu-Hong TA; Harbison MD; Salem J; Brioude F; Netchine I; Giabicani E
J Clin Endocrinol Metab; 2018 Jul; 103(7):2436-2446. PubMed ID: 29659920
[TBL] [Abstract][Full Text] [Related]
17. Meg3-DMR, not the Meg3 gene, regulates imprinting of the Dlk1-Dio3 locus.
Zhu W; Botticelli EM; Kery RE; Mao Y; Wang X; Yang A; Wang X; Zhou J; Zhang X; Soberman RJ; Klibanski A; Zhou Y
Dev Biol; 2019 Nov; 455(1):10-18. PubMed ID: 31301299
[TBL] [Abstract][Full Text] [Related]
18. Deletion of
Han X; He H; Shao L; Cui S; Yu H; Zhang X; Wu Q
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955961
[TBL] [Abstract][Full Text] [Related]
19. ZNF445: a homozygous truncating variant in a patient with Temple syndrome and multilocus imprinting disturbance.
Kagami M; Hara-Isono K; Matsubara K; Nakabayashi K; Narumi S; Fukami M; Ohkubo Y; Saitsu H; Takada S; Ogata T
Clin Epigenetics; 2021 May; 13(1):119. PubMed ID: 34039421
[TBL] [Abstract][Full Text] [Related]
20. Temple syndrome and Kagami-Ogata syndrome: clinical presentations, genotypes, models and mechanisms.
Prasasya R; Grotheer KV; Siracusa LD; Bartolomei MS
Hum Mol Genet; 2020 Sep; 29(R1):R107-R116. PubMed ID: 32592473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
